Fig. 3From: Impact of continued administration of tolvaptan on cirrhotic patients with ascitesDistribution of tolvaptan treatment period. Overall, of the patients who discontinued tolvaptan treatment, 62 discontinued within 3 months, 30 in 3–6 months, and 31 in 6 months to 1 year. Only 37 patients were treated for ≥1 year. The median treatment period was 132 daysBack to article page